Reversible phosphocholination of Rab proteins by Legionella pneumophila effector proteins

Philip R. Goody, Katharina Heller, Lena K. Oesterlin, Matthias P. Müller, Aymelt Itzen, Roger S. Goody

Publikation: Beitrag in FachzeitschriftArtikelBegutachtung

95 Zitate (Scopus)

Abstract

The Legionella pneumophila protein AnkX that is injected into infected cells by a Type IV secretion system transfers a phosphocholine group from CDP-choline to a serine in the Rab1 and Rab35 GTPase Switch II regions. We show here that the consequences of phosphocholination on the interaction of Rab1/Rab35 with various partner proteins are quite distinct. Activation of phosphocholinated Rabs by GTP/GDP exchange factors (GEFs) and binding to the GDP dissociation inhibitor (GDI) are strongly inhibited, whereas deactivation by GTPase activating proteins (GAPs) and interactions with Rab-effector proteins (such as LidA and MICAL-3) are only slightly inhibited. We show that the Legionella protein lpg0696 has the ability to remove the phosphocholine group from Rab1. We present a model in which the action of AnkX occurs as an alternative to GTP/GDP exchange, stabilizing phosphocholinated Rabs in membranes in the GDP form because of loss of GDI binding ability, preventing interactions with cellular GTPase effectors, which require the GTP-bound form. Generation of the GTP form of phosphocholinated Rab proteins cannot occur due to loss of interaction with cellular GEFs.

OriginalspracheEnglisch
Seiten (von - bis)1774-1784
Seitenumfang11
FachzeitschriftEMBO Journal
Jahrgang31
Ausgabenummer7
DOIs
PublikationsstatusVeröffentlicht - 4 Apr. 2012

Fingerprint

Untersuchen Sie die Forschungsthemen von „Reversible phosphocholination of Rab proteins by Legionella pneumophila effector proteins“. Zusammen bilden sie einen einzigartigen Fingerprint.

Dieses zitieren